REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 130 filers reported holding REVOLUTION MEDICINES INC in Q1 2021. The put-call ratio across all filers is 0.05 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,608 | -15.8% | 73,613 | -18.7% | 0.00% | 0.0% |
| Q2 2023 | $2,421,036 | +59.9% | 90,506 | +29.5% | 0.00% | 0.0% |
| Q1 2023 | $1,514,034 | +11.5% | 69,900 | +22.6% | 0.00% | +100.0% |
| Q4 2022 | $1,357,834 | +23.2% | 57,004 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $1,102,000 | +39.5% | 55,874 | +37.9% | 0.00% | 0.0% |
| Q2 2022 | $790,000 | -31.5% | 40,508 | -10.3% | 0.00% | 0.0% |
| Q1 2022 | $1,153,000 | -1.0% | 45,180 | -2.4% | 0.00% | 0.0% |
| Q4 2021 | $1,165,000 | +31.8% | 46,304 | +44.0% | 0.00% | – |
| Q3 2021 | $884,000 | +1.7% | 32,153 | +17.4% | 0.00% | – |
| Q2 2021 | $869,000 | +20.2% | 27,382 | +74.0% | 0.00% | – |
| Q1 2021 | $723,000 | -65.1% | 15,741 | -69.9% | 0.00% | -100.0% |
| Q4 2020 | $2,070,000 | +163.0% | 52,286 | +131.5% | 0.00% | – |
| Q3 2020 | $787,000 | +232.1% | 22,588 | +200.3% | 0.00% | – |
| Q2 2020 | $237,000 | – | 7,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |